-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Eagle Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2012 to 2022.
- Eagle Pharmaceuticals, Inc. Interest Expense for the quarter ending June 30, 2023 was $1.45M, a 162% increase year-over-year.
- Eagle Pharmaceuticals, Inc. Interest Expense for the twelve months ending June 30, 2023 was $6.09M, a 256% increase year-over-year.
- Eagle Pharmaceuticals, Inc. annual Interest Expense for 2022 was $4.05M, a 147% increase from 2021.
- Eagle Pharmaceuticals, Inc. annual Interest Expense for 2021 was $1.64M, a 36.6% decline from 2020.
- Eagle Pharmaceuticals, Inc. annual Interest Expense for 2020 was $2.58M, a 4.06% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)